Scenarios that move SRPT
Sarepta Therapeutics, Inc. - Common Stock
Scenarios that move SRPT: 4 analyses, 3 positive, 1 negative.
- · RARE's Fayuvi approval triggers second $203 million PRV sale — ▲ · impact +25 · confidence low · horizon quarters
- · uniQure plunges after additional Huntington's disease study data — ▼ · impact -45 · confidence high · horizon immediate
- · Satellos wins FDA IND clearance for Forazapadin in FSHD — ▲ · impact +30 · confidence low · horizon weeks
- · Ionis reports positive late-stage results for two partnered drugs — ▲ · impact +10 · confidence low · horizon weeks